US Sues Dallas Drug Compounder Over 3 Colchicine Deaths
The DOJ claims that in March 2007, ApotheCure, a compounding pharmacy, made a shipment of 72 vials of the product, used to prevent and relieve gout attacks, some of which contained much higher or much lower doses than were labeled.
ApotheCure’s alleged mislabeling amounted to two misdemeanor criminal violations of the Federal Food, Drug and Cosmetic Act. The...
To view the full article, register now.